Notes / Company

Bal Pharma Ltd.

BALPHARMA BSE 524824 ISIN INE083D01012 Pharmaceuticals

Fundamentals

Market cap: ₹133 cr
P/E: 21.10×
ROE: 9.32%
Debt / equity: 1.94
Div yield: 1.43%
52-week range: 60.00 — 104.50

Research on Tijori Finance

Company snapshot

Bal Pharma Ltd.

Pharmaceuticals

₹154 cr

P/E 18.99×

Latest quarter · Dec 2025

Sales₹88 cr

Net profit₹2 cr

Op. margin+10.9%

EPS₹1.12

Strength & growth

Debt / equity1.94×

Current ratio1.07×

Sales CAGR+4.5%

EPS CAGR+14.7%

The timeline — 1 note on Bal Pharma Ltd.

May 2026

22 May 26 · 5:40 PM IST Brief

Brief · Micro cap

Bal Pharma eyes promoter cash via warrants, but won't say how much

The board will weigh a preferential issue of warrants to insiders on May 27. The company is worth ₹134 crore and hasn't disclosed a quantum.

Verify on exchange BSE filings for BALPHARMA NSE filings for BALPHARMA Tijori Finance company page